Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.

Shanghai Bode Gene Development Co., Ltd., established on 1998-03-22, Business scope includes bioengineering,Technology transfer in the field of genetic engineering expertise,technology development,technical consulting,Technical services and manufacture of related reagents and equipment,Sales;Bioengineering and Genetic Engineering Products,electronics,Chemical Products(In addition to dangerous goods)import and export business. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

NCPC New Drug Research & Development Co. Ltd., a subsidiary of Province of Hebei, is a Chinese company located in Shijiazhuang. The firm manufactures and distributes medicines.

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cardiovascular drugs and medical devices; cephalosporin antibiotics and raw materials; and bone resorption inhibitor drugs. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China.

Far East Super Laboratories Ltd. is a private company headquartered in China that operates testing laboratories.

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

Minsheng Pharmaceutical is a chemical pharmaceutical factory. The company produces four categories of products is prescription drugs, including anti-cancer, anti-hepatitis, and cardiovascular drugs. OTC, large volume parenteral and active pharmaceutical ingredients.

Hongguan Biopharmaceutical Co., Ltd., established on 2013-04-02, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Technology Import and Export;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Industrial Design Services(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Xi'an Hengshengtang Pharmaceutical Co., Ltd., established on 1996-10-23, Business scope includes licensed business items:Capsules,tablet,Production of Granules(Limited to branch operations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General operating items:Technical consulting in medical science and technology,Technical Services,technology development,technology transfer.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The First Hospital of Jilin University, part of Jilin University, is a company headquartered in Changchun, China. The firm owns and operates hospital.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Jiangsu Hengyi Pharmaceutical Co., Ltd., established on 2009-05-13, Business scope includes drug research and development(Does not include production)and technology transfer,technical consulting,Technology intermediary service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Kunming Longjin Pharmaceutical is a biotechnology pharmaceutical company integrating research, production, supply, and sales. They develop, research, produce, and sell therapeutic drugs in the two fields of cardiovascular and cerebrovascular diseases and metabolic diseases. Their products include cardiovascular drugs, digestive medicine, vitamins, minerals, parenteral nutrition, immune system medication, and first-aid medication.

Huayi Pharmaceutical Technology (Anhui) Co., Ltd., established on 2006-12-08, Business range includes tablet,Production and sales of hard capsules;Research and development of new drugs and new dosage forms;Self-developed or owned project medical technology transfer;Pharmaceutical industry production,technology,Consulting on laws and regulations,Consultancy and personnel training services.

Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.

Hefei Jinxiang Pharmaceutical Technology Co., Ltd., established on 2014-03-27, Business scope includes food,medicine,cosmetic,R&D and technology transfer of health products,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)